Daniel V.T. Catenacci MD provides unique perspectives on medical issues within his area of expertise and can lend his research skills to various projects. Dr. Catenacci provides consultancy work for biotech and pharmaceutical companies concerning product development and validation, both analytically and clinically. He helps with the strategic positioning of novel compounds and devices, including phase 1, 2 and 3 clinical trial development and design, particularly with regulatory approval goals. In addition to helping with such project development, Dr. Catenacci also uses his consulting firm to manage other endeavors in the medical field, such as lectures and speaking events, medical-legal consultation and reviews, and online second clinical opinions for patients with gastrointestinal cancers. He has been at the helm of the enterprise for over 10 years.